KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accumulated Expenses (2016 - 2025)

Exact Sciences has reported Accumulated Expenses over the past 16 years, most recently at $416.5 million for Q4 2025.

  • Quarterly Accumulated Expenses rose 26.86% to $416.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $416.5 million through Dec 2025, up 26.86% year-over-year, with the annual reading at $416.5 million for FY2025, 26.86% up from the prior year.
  • Accumulated Expenses was $416.5 million for Q4 2025 at Exact Sciences, up from $408.8 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $416.5 million in Q4 2025 and troughed at $214.1 million in Q1 2021.
  • The 5-year median for Accumulated Expenses is $308.1 million (2022), against an average of $315.3 million.
  • Year-over-year, Accumulated Expenses surged 90.67% in 2021 and then tumbled 33.91% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $398.6 million in 2021, then fell by 24.92% to $299.2 million in 2022, then increased by 14.19% to $341.7 million in 2023, then dropped by 3.92% to $328.3 million in 2024, then rose by 26.86% to $416.5 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Accumulated Expenses are $416.5 million (Q4 2025), $408.8 million (Q3 2025), and $317.2 million (Q2 2025).